Resultados de procura - Alexander Arlantico

  • Mostrando 1 - 4 Resultados de 4
Limitar resultados
  1. 1
    LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung

    LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung por Hsiao‐Yen Ma, Qingling Li, Weng Ruh Wong, Elsa-Noah N’Diaye, Patrick Caplazi, Hannah Bender, Zhiyu Huang, Alexander Arlantico, Surinder Jeet, Aaron K. Wong, Claire Emson, Hans D. Brightbill, Lucinda Tam, Robert Newman, Merone Roose‐Girma, Wendy Sandoval, Ning Ding

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Targeted alveolar regeneration with Frizzled-specific agonists

    Targeted alveolar regeneration with Frizzled-specific agonists por Ahmad N. Nabhan, Joshua D. Webster, Jarrett Adams, Levi L. Blazer, Christine Everrett, Céline Eidenschenk, Alexander Arlantico, Isabel Fleming, Hans D. Brightbill, Paul J. Wolters, Zora Modrušan, Somasekar Seshagiri, Stéphane Angers, Sachdev S. Sidhu, Kim Newton, Joseph R. Arron, Vishva M. Dixit

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade

    Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade por Mayra Cruz Tleugabulova, Sandra P. Melo, Aaron K. Wong, Alexander Arlantico, Meizi Liu, Joshua D. Webster, J. Lau, Antonie Lechner, Basak Corak, Jonathan J. Hodgins, Venkata Garlapati, Marco De Simone, Ben Korin, Shimrit Avraham, Jessica Lund, Surinder Jeet, Alexander Reiss, Hannah Bender, Cary D. Austin, Spyros Darmanis, Zora Modrušan, Hans D. Brightbill, Steffen Durinck, Michael Diamond, Christoph Schneider, Andréy S. Shaw, Maximilian Nitschké

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis

    A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis por Ying Xi, Ryan LaCanna, Hsiao‐Yen Ma, Elsa-Noah N’Diaye, Sarah Gierke, Patrick Caplazi, Meredith Sagolla, Zhiyu Huang, Laura Lucio, Alexander Arlantico, Surinder Jeet, Hans D. Brightbill, Claire Emson, Aaron K. Wong, Katrina B. Morshead, Daryle J. DePianto, Merone Roose‐Girma, Charles Yu, Lucinda Tam, Guiquan Jia, Thirumalai R. Ramalingam, Scot A. Marsters, Avi Ashkenazi, Si‐Hyun Kim, Ryan Kelly, Shuang Wu, Paul J. Wolters, Ariel E. Feldstein, Jason A. Vander Heiden, Ning Ding

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: